Price in deferred time of 15 minutes
|
Last quote
04/19/2024 -
16:15:00
|
Bid
04/19/2024 -
16:00:00
|
Bid Volume |
Ask
04/19/2024 -
16:00:00
|
Ask Volume |
|---|---|---|---|---|
|
85.94
-0.51
(
-0.59% )
|
85.88
|
16,900 |
85.92
|
1,500 |
Analysis date: 16.04.2024
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 24.11.2023.
Interest
Weak
Weak
Weak interest since 16.04.2024.
Earnings Rev Trend
0.10
0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is positive since 26.01.2024 at a price of 73.24.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, at its current price the stock is moderately overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this (since 12.12.2023), the stock traded above its moving average. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 88.243.
4wk Rel Perf
-1.11%
-1.11%
The four week relative underperformance versus SP500 is 1.11%.
Sensibility
Middle
Middle
Moderate, no change over 1 year.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.46%.
Mkt Cap in $bn
53.64
53.64
With a market capitalization >$8bn, EDWARDS LIFESCIENCES is considered a large-cap stock.
G/PE Ratio
0.73
0.73
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
25.81
25.81
The estimated PE is for the year 2026.
LT Growth
18.77%
18.77%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
25
25
Over the last seven weeks, an average of 25 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
115
115
For 1% of index variation, the stock varies on average by 1.15%.
Correlation
0.44
0.44
43.60% of stock movements are explained by index variations.
Value at Risk
14.75
14.75
The value at risk is estimated at USD 14.75. The risk is therefore 16.39%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002